This paper describes the synthesis and preliminary
anticonvulsant evaluation of some
GABA analogues i.e. derivatives of 2-(4-phenylpiperazino)- or 2-(4-benzylpiperidino)-GABA (5, 6), N-substituted
amides of 2-(4-phenylpiperazino)-4-phthalimidobutyric
acid and N-substituted
amides of 2-(4-phenylpiperazino)-GABA. N-Substituted
amides of 2-(4-phenylpiperazino)-4-phthalimidobutyric
acid (7-11) were prepared by condensation of the
acid with the corresponding derivatives of
benzylamine in the presence of different coupling
reagents (2-chloro-4,6-dimethoxy-1,3,5-
triazine (
CDMT) and carbonyldiimidazole (CDI). N-Substituted benzylamides of 2-(4-phenylpiperazino)-
4-aminobutyric acid (12-14) were prepared by hydrazinolysis of
amides 9-11.
Anticonvulsant activities were determined in mice (for all compounds) and in rats using the subcutaneous
metrazol (scMet) and maximal electroshock (MES) screens. The
amides (12-14) showed protection against MES and/or scMet
seizures in mice. N-(4-Methoxybenzyl)-2-(4-phenylpiperazin-1-yl)-4-aminobutyric
amide (13) was the most effective and displayed
anticonvulsant activity in both tests at doses of 100-300 mg/kg in mice and at 30 mg/kg in the MES screen in rats. The active compounds (12-14) were tested for their ability to displace [3H]
nitrendipine binding sites (voltage-sensitive
calcium channel receptors) from rat cortex.
Amide 13 was the most active both in pharmacological and biochemical tests. These preliminary results suggest that the
anticonvulsant activity of compounds 12-14 may be related to their influence on voltage-sensitive
calcium channel receptors.